Release of chemical neurotransmitters by exocytosis of small synaptic vesicles (SV) forms the basis for rapid communication between neurons, whereas larger dense core vesicles (DV) contain neuropeptides necessary for neuromodulation. The machinery for exocytosis of SVs and DVs must incorporate both a basic lipid fusion apparatus, and layers of control that enable vesicular release to be restricted in time and space. The SNARE-complex, formed between vesicular VAMP/synaptobrevin, and plasma membrane located syntaxin-1 and SNAP-25, is the canonical fusion machinery (Rizo, 2018), and its mutation leads to complex neurodevelopmental disorders (Verhage and Sørensen, 2020). SNARE-complex formation is widely believed to coincide with vesicle priming, the process that renders the vesicle releasable (Sørensen et al., 2006). Upstream processes regulating SNARE-complex formation therefore become priming factors par excellence; this includes Munc18-1 and Munc13 proteins. Munc18-1 binds to an inactivated, ‘closed’ syntaxin-1 configuration (Dulubova et al., 1999). Munc13s facilitate the opening of syntaxin-1 through their catalytic MUN-domain (Ma et al., 2011; Richmond et al., 2001; Yang et al., 2015), which allows Munc18-1 to act as a template for SNARE-complex formation (Baker et al., 2015; Kalyana Sundaram et al., 2021; Parisotto et al., 2014; Shu et al., 2020; Sitarska et al., 2017). Synaptotagmin-1 binds to Ca²⁺ and triggers release in an interplay with complexin and the SNAREs themselves (Mohrmann et al., 2015; Südhof, 2013). Synaptotagmin-7 (Syt7) is a slower Ca²⁺-sensor, which is able to both trigger slow release downstream of SNARE-complex formation (Bacaj et al., 2013; Schonn et al., 2008), but also to act upstream of complex formation in a role leading to Ca²⁺-dependent vesicle priming (Liu et al., 2014; Tawfik et al., 2021). The exocytotic cascade culminates in the formation of a fusion pore through which water-soluble signaling molecules can escape (Álvarez de Toledo et al., 2018; Chang et al., 2017; Sharma and Lindau, 2018).

The vesicle priming machinery incorporates several points of regulation, triggered by receptor activation, or intracellular Ca²⁺. One of them is the binding of DAG to the C1-domain in Munc13 proteins (Betz et al., 1998), often studied using β-phorbolesters, which are DAG-mimics that potentiate release from chromaffin cells (Smith et al., 1998) and central synapses (Lou et al., 2005; Malenka et al., 1986; Shapira et al., 1987). Phorbolester targets Munc13s to the plasma membrane (Ashery et al., 2000; Betz et al., 1998). Upon mutation to unfold the C1-domain of Munc13-1 (H567K), phorbolester does not potentiate glutamatergic neurotransmission in cultured hippocampal neurons (Rhee et al., 2002). Later experiments showed that both the C1-domain and the Ca²⁺-unbound C2B-domain are inhibitory (Li et al., 2019; Michelassi et al., 2017), but inhibition can be relieved by Ca²⁺-binding to the C2B-domain, or binding of DAG to C1 (Michelassi et al., 2017). Structural studies have identified a ~20 nm elongated rod-like structure formed by the C1-C2B-MUN domain (Xu et al., 2017). The C-terminal C2C-domain on the other side of this rod binds to membranes, but not to Ca²⁺. This makes it possible for the C1-C2B-MUN-C2C structure to bridge the plasma and vesicular membranes, which is necessary for neurotransmitter release (Liu et al., 2016; Padmanarayana et al., 2021; Quade et al., 2019). Bridging can take place at different angles, depending on the binding mode at the plasma membrane; one binding mode uses a polybasic face and results in an upright/perpendicular orientation that hinders release, whereas another binding mode involves DAG-Ca²⁺-PIP₂-binding by the C1-C2B-domain, which results in a slanted orientation that facilitates release (Camacho et al., 2021). Ca²⁺/phospholipid-binding to the C2B-domain accelerates SV recruitment and reduces synaptic depression (Lipstein et al., 2021). Similar effects are seen upon calmodulin (CaM)-binding, with different penetrance in different synapses (Junge et al., 2004; Lipstein et al., 2013).

Munc13 proteins exist as different paralogs with overlapping functions. Munc13-1 is critically involved in synaptic vesicle release, with glutamate release arrested in most synapses in the absence of Munc13-1 (Augustin et al., 1999b). Munc13-2 exists as two different isoforms, due to alternative promotors; ubMunc13-2 is ubiquitously expressed, whereas bMunc13-2 is brain specific (Brose et al., 1995; Kawabe et al., 2017). Recently, mutations in Munc13-2 were linked to human epilepsy (Wang et al., 2021a). bMunc13-2 is expressed in a subset of glutamatergic synapses (Kawabe et al., 2017), and shapes paired pulse ratio and frequency facilitation at the hippocampal mossy fiber synapse (Breustedt et al., 2010). In synapses formed by pyramidal cells on GABAergic interneurons in the CA1 region of the hippocampus both Munc13-1 and Munc13-2 are expressed, but no consequences were identified upon Munc13-2 deletion (Holderith et al., 2021). Similarly, Munc13-2 deletion was without consequence in the Calyx of Held synapse (Chen et al., 2013) or the mouse photoreceptor ribbon synapse (Cooper et al., 2012). Munc13-1 is also involved in insulin secretion (Kang et al., 2006; Kwan et al., 2006; Sheu et al., 2003). In neurons, elimination of both Munc13-2 and Munc13-1 reduced the release of DVs by approximately 60%, whereas overexpression of Munc13-1 specifically increased DV secretion at extrasynaptic sites (van de Bospoort et al., 2012). ubMunc13-2 is involved in release of adrenaline/noradrenaline from adrenal chromaffin cells, as its hyper- and hypo-expression causes correlated changes in release (Man et al., 2015). Adrenal chromaffin cells also express Munc13-1, but no consequences were identified upon its deletion (Man et al., 2015). In an in vitro fusion assay, the C1-C2-MUN domain of Munc13-1 strongly stimulated fusion of synaptic vesicles, sped up fusion of insulin granules, but had no effect on DVs from PC12-cells (Kreutzberger et al., 2017; Kreutzberger et al., 2019).

Here, we set out to understand the different roles of Munc13-1 and ubMunc13-2 co-expressed in adrenal chromaffin cells (Man et al., 2015). Munc13-1 and ubMunc13-2 both contain DAG/phorbolester-binding C1-domains. We surprisingly find that phorbolester can be positive or negative for DV secretion depending on the expressed Munc13 paralog. The stimulatory effect of phorbolester on DV fusion depends on the co-expression of ubMunc13-2 and Syt7 in the same cell, identifying a stimulatory triad of ubMunc13-2, Syt7 and DAG/phorbolester for DV priming.

Mouse adrenal chromaffin cells have proven useful for deciphering the molecular basis of neurotransmitter release (Neher, 2018). Being small and compact, they are ideal for patch-clamp capacitance measurements, and release can be stimulated rapidly by Ca²⁺-uncaging (Houy et al., 2021), which bypasses Ca²⁺-influx, allowing a focus on the release machinery. Ca²⁺-uncaging empties the primed vesicle pools and allows simultaneous determination of vesicle pool sizes and fusion rates. Mouse adrenal chromaffin cells express both Munc13-1 and ubMunc13-2, encoded by the genes Unc13a and Unc13b, respectively. Previous work showed that Munc13-1 overexpression in bovine chromaffin cells (Ashery et al., 2000; Betz et al., 2001), in mouse WT cells (Stevens et al., 2005) or Unc13a/Unc13b double knockout (KO) chromaffin cells (Man et al., 2015) increased secretion, but ubMunc13-2 appeared even more potent (Man et al., 2015). Genetic deletion of Munc13-2 in mouse chromaffin cells markedly reduced secretion, whereas no effect was detected after deletion of Munc13-1 (Man et al., 2015). These findings support the notion that Munc13-1 and ubMunc13-2 play overlapping roles, with ubMunc13-2 dominating in wildtype cells, but the effect of phorbolester was not investigated.

Munc13-2 is required for the stimulatory effect of phorbolesters in chromaffin cells

To understand the molecular requirements for the well-known ability of phorbolester to stimulate secretion in chromaffin cells (Nagy et al., 2006; Smith et al., 1998), we applied Phorbol 12-Myristate 13-Acetate (PMA, 0.1 µM, applied for 5–60 min) to chromaffin cells isolated from newborn mouse Unc13b KO and WT littermates (Varoqueaux et al., 2002). We stimulated secretion by calcium uncaging, and monitored exocytosis by parallel capacitance and amperometric measurements. As expected, application of PMA doubled the secretion amplitude in Unc13b WT cells, whether measured by capacitance or amperometry (Figure 1A; traces are the mean of all measured cells). The pre-stimulation calcium concentration was ~0.9 µM, which is near the optimal concentration for calcium-dependent vesicle priming in these cells (Pinheiro et al., 2013; Tawfik et al., 2021). We performed kinetic analysis of the capacitance traces by fitting them with a sum of two exponential functions and a straight line, using an automatic fitting routine (Tawfik et al., 2021). This resulted in the determination of the two primed vesicle pools, which are denoted the Readily Releasable Pool (RRP), and the Slowly Releasable Pool (SRP). Both pools were increased significantly in size by PMA treatment (Unc13b WT, RRP = 88.1 fF±19.5 fF (mean ± SEM),+PMA, RRP = 232.2 fF±35.9 fF, Mann-Whitney test: P=0.0001, Unc13b WT, SRP = 48.1 fF±7.8 fF,+PMA, SRP = 110.4 fF±15.9 fF, Mann-Whitney test: p=0.0009; Figure 1B and E). The sustained phase of release was not significantly changed by PMA (Unc13b WT, sustained = 123.6 fF±19.8 fF,+PMA, sustained = 187.4 fF±31.3 fF, Mann-Whitney test: p=0.1641, Figure 1D). The kinetics of RRP release was slightly slower in the presence of PMA (Unc13b WT, τ_fast = 23.0 ms,+PMA, τ_fast = 30.3 ms, Mann-Whitney test: p=0.0265; Figure 1C), whereas the kinetics of SRP release was unchanged (Figure 1F).

Figure 1

Download asset Open asset

Figure 1—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig1-data1-v2.xlsx

Download elife-79433-fig1-data1-v2.xlsx

Strikingly, when we applied PMA to cultures of chromaffin cells prepared from Unc13b KO littermates, the effect of PMA was strongly inhibitory (Figure 1G), leading to a factor ~3 reduction in overall release. Kinetic analysis revealed significant reductions in RRP, SRP and sustained components (Unc13b KO, RRP = 47.9 fF±14.4 fF,+PMA, RRP = 13.6 fF±5.1 fF, Mann-Whitney test: p=0.0405, Unc13b KO, SRP = 56.0 fF±10.5 fF,+PMA, SRP = 16.5 fF±3.7 fF, Mann-Whitney test: p=0.0016, Unc13b KO, sustained = 26.2 fF±7.0 fF,+PMA, sustained = 14.4 fF±4.4 fF, Mann-Whitney test: p = 0.0496 Figure 1H, K and J). The kinetics of RRP and SRP secretion remained unchanged (Figure 1I and L). Importantly, to protect against variance between cultures, measurements with and without PMA were obtained from the same cultures originating from single animals and measured on the same days. Opposite effects of PMA on Unc13b WT and KO were detected using the same batches of PMA.

Lack of secretion upon Ca²⁺-uncaging could be expected if PMA-treatment of Unc13b KO cells led to spontaneous release, depleting the cells of secretory vesicles. To rule out this possibility, we stained Unc13b WT and KO adrenal chromaffin cells against Tyrosine Hydroxylase (TH, a marker of adrenal chromaffin cells) and chromogranin A, a releasable component of DVs. All four groups (Unc13b WT, Unc13b WT +PMA, Unc13b KO, Unc13b KO +PMA) displayed strong chromogranin staining (Figure 1M–N), with a tendency towards lower staining in the WT +PMA group (p=0.1084), that is the group with the highest secretion (Figure 1A). Quantifying the amount of CgA staining close to the membrane also did not result in significant differences (Figure 1O). Thus, Unc13b KO cells have intact secretory potential with and without PMA.

These data show that in mouse adrenal chromaffin cells, ubMunc13-2 is required for phorbolester to stimulate secretion, and in its absence, phorbolester is inhibitory. Phorbolesters also activate Protein kinase C (PKC), which stimulates secretion, but apparently this effect does not prevail in the absence of ubMunc13-2, probably due to an overall weak PKC-dependence of secretion from newborn or embryonic mouse chromaffin cells (see Discussion).

Phorbolesters are more potent in the absence of Munc13-1

We next investigated the consequence of deleting Munc13-1 for the effect of PMA. To this end, we performed measurements in Unc13a WT and KO littermate cultures. Strikingly, PMA stimulation of Unc13a KO cells led to a higher overall secretion level than in Unc13a WT cells treated with PMA (Figure 2A, traces are mean of all measured cells). Kinetic analysis showed that PMA stimulated the RRP size in both Unc13a WT and Unc13a KO (Unc13a WT, RRP = 36.9 fF±7.0 fF,+PMA, RRP = 88.5 fF±11.9 fF, Unc13a KO, RRP = 44.4 fF±7.7 fF,+PMA, RRP = 169.2 fF±37.9 fF, Kruskal-Wallis test – Dunn’s multiple comparisons test WT vs WT PMA p=0.0091; KO vs KO PMA p=0.0288, Figure 2B). On average, the RRP was larger in the Unc13a KO +PMA than in the Unc13a WT +PMA (169.2 fF ±37.9 fF vs RRP = 88.5 fF±11.9 fF), but the difference did not reach statistical significance. The SRP-size was significantly larger in the Unc13a KO +PMA than in the Unc13a WT +PMA group (Unc13a WT, SRP = 29.8 fF±7.9 fF,+PMA, SRP = 45.4 fF±7.0 fF, Unc13a KO, SRP = 40.5 fF±9.5 fF,+PMA, SRP = 95.6 fF±14.2 fF, Kruskal-Wallis test – Dunn’s multiple comparisons test: KO vs KO PMA p=0.0048; WT PMA vs KO PMA p=0.0437; WT vs KO PMA p=0.0003, Figure 2E). The sustained release and the kinetics of RRP and SRP fusion were not significantly different between conditions (Figure 2C, D and F). The hypothesis that PMA has a larger effect in Unc13a KO than in Unc13a WT can also be tested by arranging the data in a two-way ANOVA, with genotype and drug application (with or without PMA) as orthogonal factors. The hypothesis then becomes identifiable as a significant interaction between the two factors. Indeed, performing this analysis showed that the interaction was close to significant in both cases (p=0.0562 for RRP size and p=0.0442 for SRP size), indicating a likely interaction between the two factors, which was again significant for the SRP.

Figure 2

Download asset Open asset

Figure 2—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig2-data1-v2.xlsx

Download elife-79433-fig2-data1-v2.xlsx

When comparing the two mouse lines, the secretory amplitude was larger in the Unc13b WT than in Unc13a WT, especially in the presence of PMA (Figure 2A vs Figure 1A). However, Unc13a WT and Unc13b WT cultures were not prepared in parallel. Moreover, because Unc13a is perinatally lethal (Augustin et al., 1999a) we used embryonic animals (18. embryonic day) for Unc13a KO and WT, whereas for Unc13b WT and KO, we used postnatal (P0-P2) animals (Materials and Methods). The data sets are therefore not directly comparable.

Overall, phorbolester is more potent in the absence of Munc13-1, consistent with the notion that functional interaction of phorbolester with endogenous Munc13-1 interaction is negative for secretion in chromaffin cells.

Overexpressed Munc13-1 and Munc13-2 display different trafficking and phorbolester effects

Next, we overexpressed each Munc13 paralog (Munc13-1, ubMunc13-2) separately, and investigated whether the effect of phorbolester would differ when either paralog would dominate the cell. These experiments made use of the Munc13-1-EGFP and ubMunc13-2-EGFP Semliki Forest Virus (SFV) constructs previously used for expression in bovine or mouse chromaffin cells (Ashery et al., 2000; Man et al., 2015; Zikich et al., 2008). We took advantage of the EGFP-tag to visualize trafficking of Munc13 following Ca²⁺-uncaging using a CCD camera (Figure 3—figure supplement 1). Thus, before and after the uncaging flash, cells were illuminated by 488 nm light to visualize EGFP. This was possible using the same (fura-containing) pipette solution, because 488 nm light does not excite fura dyes. Although in these measurements we did not measure [Ca²⁺]_i, we could measure [Ca²⁺] in separate experiments using identical flash lamp setting, dichroic mirror, objective, and pipette solution (see Materials and Methods). Thereby, we established that these measurements led to a pre-stimulation [Ca²⁺]_i = 0.64 µM±0.09 µM and a post-stimulation [Ca²⁺]_i = 26.8 µM±1.8 µM (means ± SEM, n=14) (Figure 3—figure supplement 2). Some measurements might deviate from this range. Successful expression of Munc13-1-EGFP and ubMunc13-2-EGFP was verified by Western blotting of SFV-infected HEK-cells (Figure 3—figure supplement 3A), and quantification of EGFP fluorescence from single chromaffin cells (Figure 3—figure supplement 3B). We imaged Munc13-1-EGFP, ubMunc13-2-EGFP and the H567K-mutation of Munc13-1-EGFP, which does not bind to phorbolesters (Betz et al., 1998), while applying PMA (Figure 3—figure supplement 4). As expected, Munc13-1-EGFP and ubMunc13-2-EGFP, but not Munc13-1-EGFP H567K translocated to the plasma membrane over the course of several minutes. This time course most likely reflects the time it takes for PMA to penetrate the cell, combined with the time it takes for Munc13 to diffuse to the plasma membrane in the absence of increased [Ca²⁺]. Since the capacitance measurements above indicated that the main effect of PMA is on secretion amplitude, not kinetics (see also Nagy et al., 2006), we simplified the analysis and only distinguished between burst secretion (first 1 s secretion after Ca²⁺ uncaging, corresponding approximately to RRP and SRP fusion) and sustained secretion (last 4 s of secretion), as well as total secretion (the sum of burst and sustained release).

Expression of ubMunc13-2-EGFP in Unc13b KO cells resulted in large secretory amplitude, ~800 fF (Figure 3B). In response to PMA, secretion was increased even further, resulting in an increase in burst size, total and sustained secretion; the two former effects were statistically significant (Burst - Overexpressed (OE) ubMunc13-2-EGFP: 239.09 fF ±25.96 fF,+PMA: 628.72 fF ±119.64 fF, Mann-Whitney test: p=0.0314; Total - OE ubMunc13-2 EGFP: 808.93 fF ±107.82 fF,+PMA: 1344.53 fF ±178.70 fF, Mann-Whitney test: p=0.0479; Sustained - OE ubMunc13-2-EGFP: 570.22 fF ±87.67 fF; 714.66±89.75, Mann-Whitney test: p=0.2992; Figure 3D). ubMunc13-2-EGFP was present in the cytosol (Figure 3A top panels), but upon uncaging, part of the protein trafficked to the plasma membrane within a few seconds, with a kinetics roughly matching sustained release - in Figure 3B the normalized PM fluorescence was replotted behind the capacitance trace to allow a comparison (Figure 3A–B; Figure 3—figure supplement 5A). Upon application of PMA, ubMunc13-2-EGFP was already at the plasma membrane and did not traffic further upon Ca²⁺ increase (Figure 3A bottom panels, Figure 3B, Figure 3—figure supplement 5B). To test the significance of the Ca²⁺-dependent trafficking, we could use the trafficking index at 5 s compared to preflash values. However, in principle the uncaging flash itself could change our measure of PM localization (total fluorescence divided by fluorescence in the cytosol), because it represents a strong flash of ultraviolet light that could lead to bleaching of both EGFP and background fluorescence. If bleaching of EGFP and background are not exactly proportional, the measure of PM localization could change even in the absence of trafficking. Therefore, we compared trafficking at 5 s after uncaging in the absence of PMA to the PMA-group, since the PMA group did not show significant trafficking by virtue of being already at the plasma membrane. This showed that Ca²⁺-dependent trafficking was highly significant (Mann-Whitney test: p<0.0001; Figure 3C).

Figure 3 with 5 supplements see all

Download asset Open asset

Figure 3—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig3-data1-v2.xlsx

Download elife-79433-fig3-data1-v2.xlsx

Expression of Munc13-1-EGFP in Unc13a KO cells resulted in approximately 400 fF secretion (Figure 4B), more than in the Unc13a WT (Figure 2), although we here compare experiments not carried out in parallel. Munc13-1-EGFP localized to the cytosol, with part of the protein found in larger accumulations in some, but not all cells (compare different examples in Figure 4A, Figure 5A, Figure 4—figure supplement 1A, Figure 7—figure supplement 1). We speculated that the accumulations might be related to the higher average expression level of Munc13-1 compared to ubMunc13-2, as assessed by cellular EGFP fluorescence (Figure 3—figure supplement 3B). Expression of the Munc13-1-EGFP for shorter times (than the standard 12–17 hr, Materials and methods) was attempted, but this was not successful because of a lack of consistent expression as detected by EGFP fluorescence. Upon PMA application, part of the protein localized to the plasma membrane (Figure 4A; Figure 3—figure supplement 4). As a further indication that Munc13-1-EGFP is functional, we expressed it in cells from CD1-mice (an outbred mouse strain). Expression caused a clear and statistically significant increase in total and sustained secretion (Figure 4—figure supplement 1). We verified the sequence of both the Munc13-1-EGFP and ubMunc13-2-EGFP expression plasmids (Materials and Methods). Although some individual cells displayed EGFP-Munc13-1 trafficking (Figure 4—figure supplement 2), overall little membrane trafficking was induced by increasing calcium in Munc13-1-EGFP expressing cells (Figure 4B–C). Following PMA-application, total, burst and sustained secretion were reduced; the effects on total and burst secretion were statistically significant (Burst - OE Munc13-1-EGFP: 136.92 fF ±26.09 fF,+PMA: 68.34 fF ±9.10 fF, Mann-Whitney test: p=0.0117; Total - OE Munc13-1-EGFP: 414.22 fF ±69.47 fF,+PMA: 219.53 fF ±34.35 fF, Mann-Whitney test: p=0.0182; Sustained - OE Munc13-1-EGFP: 273.30 fF ±52.75 fF; 150.9±32.07, Mann-Whitney test: p=0.0793; Figure 4B and D). These data indicate that PMA-induced stimulation of Munc13-1 is inhibitory for DV secretion in chromaffin cells, in agreement with findings above in the Unc13a and Unc13b mouse lines. As a control, we expressed the Munc13-1 H567K mutation, which does not bind to phorbolesters (Betz et al., 1998) in adrenal chromaffin cells from CD1 mice. Upon expression, there was no effect of PMA (Figure 4—figure supplement 3), which agrees with previous data from bovine chromaffin cells (Bauer et al., 2007).

Figure 4 with 3 supplements see all

Download asset Open asset

Figure 4—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig4-data1-v2.xlsx

Download elife-79433-fig4-data1-v2.xlsx

Figure 5

Download asset Open asset

Figure 5—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig5-data1-v2.xlsx

Download elife-79433-fig5-data1-v2.xlsx

Thus, evidence from both Munc13-1-EGFP overexpression and Unc13a KO as well as Unc13b KO indicate that PMA interacting with Munc13-1 is inhibitory, whereas PMA interacting with ubMunc13-2 is positive for DV secretion. Since ubMunc13-2 supports more secretion than Munc13-1 upon overexpression in parallel experiments (Man et al., 2015), it is possible that the apparent negative effect of Munc13-1 could be due to competition with ubMunc13-2, because targeting Munc13-1 to the plasma membrane with PMA might displace the more potent ubMunc13-2. To investigate this, we expressed Munc13-1-EGFP in Unc13b KO cells (Figure 5A–D). Even under these circumstances, PMA application led to a significant decrease in total and sustained secretion, but the secretory burst was now unaffected (Burst - OE Munc13-1-EGFP: 104.64 fF ±20.58 fF,+PMA: 104.47 fF ±18.30 fF, Mann-Whitney test: p=0.8280; Total - OE Munc13-1-EGFP: 452.45 fF ±62.21 fF,+PMA: 210.43 fF ±50.40 fF, Mann-Whitney test: p<0.0001; Sustained - OE Munc13-1-EGFP: 347.8 fF ±63.42 fF;+PMA: 106±38.75, Mann-Whitney test: p=0.0001; Figure 5D). Thus, the ability of PMA and Munc13-1 to suppress the burst might be due to displacement of ubMunc13-2, but ubMunc13-2 is not required for the overall inhibitory nature of PMAs interaction with Munc13-1.

Synaptotagmin-7, ubMunc13-2 and phorbolester form a stimulatory triad for vesicle fusion

We previously showed that Syt7 is involved in calcium and phorbolester-induced priming of chromaffin cells DVs (Tawfik et al., 2021). We here set out to understand whether the different abilities of ubMunc13-2 and Munc13-1 to support DV secretion in the presence of PMA depends on syt7.

We first expressed ubMunc13-2-EGFP in Syt7 KO and WT cells. As previously reported (Tawfik et al., 2021), expression of ubMunc13-2 resulted in massive secretion in both the Syt7 KO and WT, but secretion was delayed in Syt7 KO (Figure 6B). As a result, the burst size, as defined by secretion within the first second, was significantly reduced in Syt7 KO cells expressing EGFP-ubMunc13-2 compared to Syt7 WT expressing EGFP-ubMunc13-2 (Burst - OE ubMunc13-2-eGFP in Syt7 WT: 317.01 fF ±53.24 fF, OE Munc13-2-EGFP in Syt7 KO: 150.21 fF ±24.91 fF, Mann-Whitney test: p=0.0286, Figure 6D; for other values see Source Data File). Imaging showed that in spite of the delayed secretion in the Syt7 KO, ubMunc13-2-EGFP trafficking was unchanged (Figure 6A–B), and – consequently – ubMunc13-2-EGFP trafficking preceded exocytosis in the Syt7 KO ubMunc13-2 overexpressing cells (Figure 6B bottom panel). Therefore, calcium-dependent ubMunc13-2-EGFP trafficking is independent of Syt7. To investigate this further, we performed co-immunoprecipations between b/ubMunc13-2 and Syt7, as well as between Munc13-1 and Syt7 (Materials and methods). However, we failed to identify any interaction (Figure 6—figure supplement 1). Therefore, any functional interaction between Syt7 and Munc13-2 does not seem to involve direct stable binding or co-trafficking, but transient interactions cannot be ruled out.

Figure 6 with 1 supplement see all

Download asset Open asset

Figure 6—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig6-data1-v2.xlsx

Download elife-79433-fig6-data1-v2.xlsx

To shed further light on the interaction between PMA, Munc13-2 and Syt7, we applied PMA to Syt7 KO cells expressing ubMunc13-2-EGFP (Figure 7). Strikingly, in these cells, PMA was strongly inhibitory for secretion (Figure 7D), leading to a statistically significant decrease in total and sustained secretion, whereas the burst was non-significantly reduced (Burst - OE ubMunc13-2-EGFP in Syt7 KO: 220.51 fF ±51.60 fF,+PMA: 185.45 fF ±53.19 fF, Mann-Whitney test: p=0.3989; Total - OE ubMunc13-2-EGFP in Syt7 KO: 896.60 fF ±199.86 fF,+PMA: 223.03 fF ±53.60 fF, Mann-Whitney test: p=0.0002; Sustained - OE ubMunc13-2-EGFP in Syt7 KO: 676.34 fF ±156.89 fF;+PMA: 37.43±15.53, Mann-Whitney test: p<0.0001; Figure 7D). Similar to data obtained above, ubMunc13-2 trafficked to the PM after a calcium increase (Figure 7A–C). In a final experiment, we showed that in Syt7 KO cells expressing Munc13-1, PMA was also inhibitory for both total and sustained secretion (Figure 7—figure supplement 1). Overall, the difference between Munc13-1 and ubMunc13-2 in their response to PMA lies in the specific ability of ubMunc13-2 to interact productively with Syt7; in the absence of Syt7, PMA interacting with ubMunc13-2 is negative for secretion, as is the case for Munc13-1.

Figure 7 with 2 supplements see all

Download asset Open asset

Figure 7—source data 1

Quantitative data.

https://cdn.elifesciences.org/articles/79433/elife-79433-fig7-data1-v2.xlsx

Download elife-79433-fig7-data1-v2.xlsx

Previous investigations did not resolve the function of Munc13-1 in chromaffin cells, since no consequences of eliminating Munc13-1 were identified (Man et al., 2015), while other studies showed that overexpression of Munc13-1 increased secretion in bovine chromaffin cells (Ashery et al., 2000; Betz et al., 2001) or mouse Unc13a/Unc13b double knockout chromaffin cells (Man et al., 2015). Here, we reproduced the positive effect of Munc13-1 overexpression in WT cells (Figure 4—figure supplement 1), but the increase in burst secretion was smaller in our hands than reported earlier upon expression in bovine chromaffin cells (Ashery et al., 2000; Betz et al., 2001). This can be due to differences in species or age of the experimental animals (embryonic/newborn mice vs adult cow). It might also be due to differences in prestimulation Ca²⁺ concentrations, which were not measured in each cell in our experiment and not measured in the work on bovine cells. We also reproduced the lack of consequences of Munc13-1 elimination (Figure 2; Man et al., 2015). However, we surprisingly found that the dominating Munc13 paralog determines the effect of phorbolester (PMA), such that PMA is inhibitory when Munc13-1 dominates, but stimulatory when ubMunc13-2 is prevalent. The evidence supporting this conclusion is:

1. In the Unc13b WT mouse, PMA was stimulatory for secretion, in agreement with the higher endogenous expression level of ubMunc13-2 than Munc13-1 (Man et al., 2015). In Unc13b KO mouse (expressing endogenous Munc13-1, but no ubMunc13-2), PMA became inhibitory for secretion.

2. In the Unc13a KO mouse, PMA was more stimulatory for secretion than in the Unc13a WT mouse, consistent with a negative function for endogenous Munc13-1 in the presence of PMA.

3. Upon overexpression of ubMunc13-2, PMA was stimulatory for secretion (as in WT cells).

4. Upon overexpression of Munc13-1, PMA became inhibitory for secretion, whether overexpression was in Unc13a KO (still expressing ubMunc13-2) or in Unc13b KO cells.

The identification of opposite effects of phorbolester for DV secretion depending on the predominant expression of Munc13-1 and ubMunc13-2 is surprising, given their ability to cross-rescue (Man et al., 2015; Rosenmund et al., 2002). However, a difference in phorbolester-effect of Munc13-1 and ubMunc13-2 was detected before, as the positive effect of phorbolester on synaptic release was larger in ubMunc13-2 than in Munc13-1 expressing Unc13a/Unc13b double KO glutamatergic neurons (Rosenmund et al., 2002). Nevertheless, phorbolester interacting with Munc13-1 is clearly stimulatory for glutamate release (Rosenmund et al., 2002).

The effect of phorbolester on Munc13s is partly to recruit the protein to the plasma membrane by binding to the C1-domain, and partly to release an inhibitory effect of the (DAG and Ca²⁺ unbound) C1-C2B domain (Michelassi et al., 2017). Previous findings in chromaffin cells showed that overexpression of Doc2B boosts the secretory burst, which required an intact Munc13-binding domain (the MID domain Friedrich et al., 2013; Michelassi et al., 2017) and the presence of ubMunc13-2, making it possible for Doc2B to target ubMunc13-2 to the plasma membrane (Orita et al., 1997). However, in the absence of ubMunc13-2 (i.e. in Unc13b KO cells), overexpression of Doc2B became strongly inhibitory (Houy et al., 2017). This inhibitory function of Doc2B aligns with its ability to target Munc13-1 (present in Unc13b KO cells) to the plasma membrane (Friedrich et al., 2013; Houy et al., 2017) and agrees with our findings here that plasma membrane targeting of Munc13-1 by PMA is inhibitory for chromaffin cell DV secretion.

Apart from its ability to bind Munc13s, phorbolester also activates protein kinase C (PKC), which has effects on chromaffin cell excitability, calcium homeostasis, and secretion (Fulop and Smith, 2006; Kuri et al., 2009; Park et al., 2006; Rosmaninho-Salgado et al., 2007; Smith et al., 1998; Soma et al., 2009; Staal et al., 2008). Using whole-cell voltage clamp and calcium-uncaging, effects on excitability and calcium homeostasis are effectively bypassed, allowing us to focus on the secretory machinery in the present study. In neurons, the effects of phorbolester have been attributed both to Munc13-1 C1-activation, and PKC-activation (Rhee et al., 2002; Wierda et al., 2007). PKC phosphorylates exocytotic proteins, including Munc18-1 (Genc et al., 2014; Wierda et al., 2007) and synaptotagmin-1 (de Jong et al., 2016), and these phosphorylation events are required for full potentiation of synaptic transmission after train stimulation or PMA application, respectively (but see Wang et al., 2021b). Phosphorylation of Munc18-1 also potentiates secretion from adult bovine chromaffin cells (Nili et al., 2006). However, PKC-dependent modulation of the release machinery appears weaker or absent in embryonic or newborn mouse chromaffin cells, since blocking Munc18-1 or synaptotagmin-1 phosphorylation have no detectable consequences, either in control conditions, or after PMA application (Nagy et al., 2006; Nili et al., 2006). Furthermore, we have shown that blocking PKC-activity has no consequences for capacitance increases during Ca²⁺-uncaging in chromaffin cells, if only one Ca²⁺-stimulation is used (Nagy et al., 2002; Nili et al., 2006). We confirmed that here for both Unc13b WT and KO cells, using a broad spectrum PKC inhibitor (Gö6983, Figure 7—figure supplement 2). However, although membrane fusion was unaffected, the amperometric signal was reduced, reflecting a reduced release of adrenaline/noradrenaline – this effect of PKC inhibition was noted before (Fulop and Smith, 2006; Staal et al., 2008). These observations are in agreement with our finding that Munc13-2 is absolutely required for the stimulatory effect of phorbolester on capacitance increase (Figure 1); however, we cannot rule out an interaction between PKC-dependent phosphorylation and Munc13 activation.

Even though overexpression of ubMunc13-2 results in the most potent secretion from chromaffin cells so far known (Man et al., 2015; Zikich et al., 2008), secretion could be potentiated further with phorbolester (Figure 3). However, phorbolester was inhibitory in cells not expressing Syt7 (Figure 7). The inhibitory effect depended upon the overexpression of ubMunc13-2, as it was not found in non-overexpressing Syt7 KO cells (Tawfik et al., 2021); indeed, the reduction in secretion by application of PMA brings secretion back to approximately the level in Syt7 KO cells not overexpressing ubMunc13-2 (Tawfik et al., 2021), which indicates that it is the increase in secretion by ubMunc13-2 overexpression which is reversed by PMA in this case. Overall, an interaction between Syt7, ubMunc13-2 and DAG/phorbolester ensures optimal vesicle priming. We previously showed that although phorbolester was ineffective in the absence of Syt7 at low prestimulation [Ca²⁺], at higher prestimulation [Ca²⁺] it regained some potency (Tawfik et al., 2021); therefore, in the absence of Syt7 other Ca²⁺-sensors can substitute in the stimulatory ‘triad’, most likely Syt1 or Doc2B (Houy et al., 2017).

We could not detect any effect of Syt7 on Ca²⁺-dependent ubMunc13-2 trafficking, which likely is driven by Ca²⁺-binding to the ubMunc13-2 C2B-domain, or any direct binding in co-immunoprecipitation experiments. Instead, we suggest that the interaction is functional, and a likely explanation is the observation that in the Syt7 KO, vesicles accumulate at 20–40 nm distance to the plasma membrane (Tawfik et al., 2021). This distance is out of range of the rod-shaped elongated structure formed by Munc13 proteins (Quade et al., 2019; Xu et al., 2017). Recruitment of ubMunc13-2 to the plasma membrane in the absence of Syt7 will therefore not lead to productive bridging of vesicular and plasma membrane, and vesicle priming. Instead, the recruited ubMunc13-2 might inhibit release, by steric hindrance, by adopting an orientation that will not promote membrane bridging (Camacho et al., 2021; Grushin et al., 2022), or by covering up PIP₂-patches in the plasma membrane, which are necessary for vesicle priming and fusion (Aoyagi et al., 2005; James et al., 2008; Milosevic et al., 2005).

Even though phorbolester became inhibitory when Munc13-1 dominated, expression of Munc13-1 did increase secretion in the absence of phorbolester. Munc13-1 is therefore able to stimulate priming or fusion of DVs. Another difference between Munc13-1-EGFP and ubMunc13-2-EGFP was the ability of the latter to traffic to the membrane in parallel with the sustained part of the capacitance trace following an abrupt Ca²⁺ increase. This indicates that ubMunc13-2 recruitment to the plasma membrane might be rate limiting for vesicle priming during sustained secretion. We did not see strong Ca²⁺-dependent recruitment of Munc13-1-EGFP to the membrane (over the course of ~5 s; note that it could recruit over longer times). Phorbolester recruited Munc13-1 to the plasma membrane, but caused inhibition of secretion. Together, these findings suggest that Munc13-1 might not act at the plasma membrane in priming of DVs. Another indication for an action at the vesicular level is the previous observation that the positive effect of Munc13-1-EGFP expression depends on the expression of CAPS proteins, and in CAPS-1/2 DKO chromaffin cells overexpression of Munc13-1-EGFP inhibited secretion (Liu et al., 2010). CAPS is a vesicle-associated protein (Ann et al., 1997; Kabachinski et al., 2016), which contains a SNARE-binding MUN-domain (as Munc13s) and a PIP2-binding PH domain. The PH-domain is essential for its action in vesicle exocytosis (Grishanin et al., 2004; James et al., 2010; Nguyen Truong et al., 2014), as it directs vesicles to dock and prime at PIP₂-sites on the plasma membrane (Kabachinski et al., 2016). CAPS and Munc13 proteins do not cross-rescue (Jockusch et al., 2007; Kabachinski et al., 2014), but ubMunc13-2 can overcome the need for CAPS when DAG is abundant, due to binding to ubMunc13-2’s C1-domain (Kabachinski et al., 2014). This effect is likely related to the stimulatory effect of phorbolester in the presence of ubMunc13-2 that we identified here.

The negative effect of Munc13-1 in the presence of phorbolester could be caused by recruitment of Munc13-1 to the plasma membrane, which takes it away from its CAPS-dependent role, or it could be caused by the displacement of ubMunc13-2 at the plasma membrane. Both effects are apparently involved, since expression of Munc13-1-EGFP in the presence of endogenous ubMunc13-2 inhibited the burst (Figure 4), which was not the case when Munc13-1-EGFP was expressed in Unc13b KO cells (Figure 5). Nevertheless, the data also indicate that there is a negative effect of PMA x Munc13-1, which is independent of Munc13-2.

Our data seem at odds with previous finding that expressing the Munc13-1 DAG-insensitive H567K mutant attenuated the effect of histamine in bovine chromaffin cells (Bauer et al., 2007). Histamine acts on G_q-coupled H1-receptors to increase DAG levels in chromaffin cells. However, the observations are probably consistent, because overexpressing the Munc13-1 H567K-mutation might overwhelm endogenous ubMunc13-2. Indeed, upon overexpression of Munc13-1 H567K, phorbolester was without effect (Figure 4—figure supplement 3).

Given the very similar domain structure of Munc13-1 and ubMunc13-2, it is surprising to find different functions of the two proteins in DV fusion. However, it has already been reported that the C1-C2-MUN domain of Munc13-1 stimulates SV fusion, but not DV fusion in an in vitro assay (Kreutzberger et al., 2017; Kreutzberger et al., 2019). Several possibilities might explain these findings. Munc13-1 is a slightly longer protein that harbors an additional stretch of amino acids with unknown function immediately N-terminal of the CaM-binding site (Lipstein et al., 2012). This stretch might confer preferential interaction with SVs over DVs, or it might interact with the membrane. Another possibility is that there might be subtle differences in the length, shape or angle with the PM of the rod-like domain in Munc13-1 and ubMunc13-2, which bridges vesicular and plasma membrane (Padmanarayana et al., 2021; Quade et al., 2019; Xu et al., 2017). Strikingly, there is evidence that Munc13-1 can adopt different angles on the plasma membrane (Grushin et al., 2022) and that the predominant angle changes upon binding to DAG via its C1-domain (Camacho et al., 2021). For priming to occur, the angle might need to accurately fit the curvature of the vesicle, which is markedly different for SVs and DVs. A difference in the angle formed by DAG-bound Munc13-1 and ubMunc13-2 could confer preferential function towards SVs or DVs, respectively. A difference in the ability to oligomerize between vesicular membrane and PM might also be involved (Grushin et al., 2022). However, until now comparative structural studies of ubMunc13-2 and Munc13-1 that could help solve this question are missing.

Overall, we found two striking differences between Munc13-1 and ubMunc13-2 in chromaffin cells: only ubMunc13-2 traffics to the plasma membrane with a time course matching secretion after an [Ca²⁺] increase, and only ubMunc13-2 supports more secretion in the presence of phorbolester. The latter effect depends on endogenous Syt7 expression, indicating that Munc13-2, Syt7 and DAG/phorbolesters form a stimulatory triad for DV fusion. As a consequence of the inability of Munc13-1 to substitute for ubMunc13-2 action, the ubMunc13-2/Munc13-1 ratio might determine the effect of DAG/phorbolesters/ in chromaffin cells.

All data generates or analysed during this study are included in the manuscript and supporting files; the source data files contain the numerical data used to generate the figures.

1. 1. Álvarez de Toledo G
   2. Montes MÁ
   3. Montenegro P
   4. Borges R

   (2018) Phases of the exocytotic fusion pore

   FEBS Letters 592:3532–3541.

   https://doi.org/10.1002/1873-3468.13234

   • PubMed
   • Google Scholar
2. 1. Ann K
   2. Kowalchyk JA
   3. Loyet KM
   4. Martin TF

   (1997) Novel Ca2+-binding protein (CAPS) related to UNC-31 required for Ca2+-activated exocytosis

   The Journal of Biological Chemistry 272:19637–19640.

   https://doi.org/10.1074/jbc.272.32.19637

   • PubMed
   • Google Scholar
3. 1. Aoyagi K
   2. Sugaya T
   3. Umeda M
   4. Yamamoto S
   5. Terakawa S
   6. Takahashi M

   (2005) The activation of exocytotic sites by the formation of phosphatidylinositol 4,5-bisphosphate microdomains at syntaxin clusters

   The Journal of Biological Chemistry 280:17346–17352.

   https://doi.org/10.1074/jbc.M413307200

   • PubMed
   • Google Scholar
4. 1. Ashery U
   2. Betz A
   3. Xu T
   4. Brose N
   5. Rettig J

   (1999) An efficient method for infection of adrenal chromaffin cells using the Semliki Forest virus gene expression system

   European Journal of Cell Biology 78:525–532.

   https://doi.org/10.1016/s0171-9335(99)80017-x

   • PubMed
   • Google Scholar
5. 1. Ashery U
   2. Varoqueaux F
   3. Voets T
   4. Betz A
   5. Thakur P
   6. Koch H
   7. Neher E
   8. Brose N
   9. Rettig J

   (2000) Munc13-1 acts as a priming factor for large dense-core vesicles in bovine chromaffin cells

   The EMBO Journal 19:3586–3596.

   https://doi.org/10.1093/emboj/19.14.3586

   • PubMed
   • Google Scholar
6. 1. Augustin I
   2. Betz A
   3. Herrmann C
   4. Jo T
   5. Brose N

   (1999a)

   Differential expression of two novel munc13 proteins in rat brain

   The Biochemical Journal 337 (Pt 3):363–371.

   • PubMed
   • Google Scholar
7. 1. Augustin I
   2. Rosenmund C
   3. Südhof TC
   4. Brose N

   (1999b) Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles

   Nature 400:457–461.

   https://doi.org/10.1038/22768

   • PubMed
   • Google Scholar
8. 1. Bacaj T
   2. Wu D
   3. Yang X
   4. Morishita W
   5. Zhou P
   6. Xu W
   7. Malenka RC
   8. Südhof TC

   (2013) Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release

   Neuron 80:947–959.

   https://doi.org/10.1016/j.neuron.2013.10.026

   • PubMed
   • Google Scholar
9. 1. Baker RW
   2. Jeffrey PD
   3. Zick M
   4. Phillips BP
   5. Wickner WT
   6. Hughson FM

   (2015) A direct role for the sec1/munc18-family protein VPS33 as a template for SNARE assembly

   Science 349:1111–1114.

   https://doi.org/10.1126/science.aac7906

   • PubMed
   • Google Scholar
10. 1. Bauer CS
    2. Woolley RJ
    3. Teschemacher AG
    4. Seward EP

    (2007) Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13-1

    The Journal of Neuroscience 27:212–219.

    https://doi.org/10.1523/JNEUROSCI.4201-06.2007

    • PubMed
    • Google Scholar
11. 1. Betz A
    2. Ashery U
    3. Rickmann M
    4. Augustin I
    5. Neher E
    6. Südhof TC
    7. Rettig J
    8. Brose N

    (1998) Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release

    Neuron 21:123–136.

    https://doi.org/10.1016/s0896-6273(00)80520-6

    • PubMed
    • Google Scholar
12. 1. Betz A
    2. Thakur P
    3. Junge HJ
    4. Ashery U
    5. Rhee JS
    6. Scheuss V
    7. Rosenmund C
    8. Rettig J
    9. Brose N

    (2001) Functional interaction of the active zone proteins munc13-1 and RIM1 in synaptic vesicle priming

    Neuron 30:183–196.

    https://doi.org/10.1016/s0896-6273(01)00272-0

    • PubMed
    • Google Scholar
13. 1. Breustedt J
    2. Gundlfinger A
    3. Varoqueaux F
    4. Reim K
    5. Brose N
    6. Schmitz D

    (2010) Munc13-2 differentially affects hippocampal synaptic transmission and plasticity

    Cerebral Cortex 20:1109–1120.

    https://doi.org/10.1093/cercor/bhp170

    • PubMed
    • Google Scholar
14. 1. Brose N
    2. Hofmann K
    3. Hata Y
    4. Südhof TC

    (1995) Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins

    The Journal of Biological Chemistry 270:25273–25280.

    https://doi.org/10.1074/jbc.270.42.25273

    • PubMed
    • Google Scholar
15. 1. Bruns D

    (2004) Detection of transmitter release with carbon fiber electrodes

    Methods 33:312–321.

    https://doi.org/10.1016/j.ymeth.2004.01.004

    • PubMed
    • Google Scholar
16. 1. Camacho M
    2. Quade B
    3. Trimbuch T
    4. Xu J
    5. Sari L
    6. Rizo J
    7. Rosenmund C

    (2021) Control of neurotransmitter release by two distinct membrane-binding faces of the munc13-1 c1c2b region

    eLife 10:72030.

    https://doi.org/10.7554/eLife.72030

    • Google Scholar
17. 1. Chang CW
    2. Chiang CW
    3. Jackson MB

    (2017) Fusion pores and their control of neurotransmitter and hormone release

    The Journal of General Physiology 149:301–322.

    https://doi.org/10.1085/jgp.201611724

    • PubMed
    • Google Scholar
18. 1. Chen Z
    2. Cooper B
    3. Kalla S
    4. Varoqueaux F
    5. Young SM

    (2013) The munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse

    The Journal of Neuroscience 33:8336–8351.

    https://doi.org/10.1523/JNEUROSCI.5128-12.2013

    • PubMed
    • Google Scholar
19. 1. Cooper B
    2. Hemmerlein M
    3. Ammermüller J
    4. Imig C
    5. Reim K
    6. Lipstein N
    7. Kalla S
    8. Kawabe H
    9. Brose N
    10. Brandstätter JH
    11. Varoqueaux F

    (2012) Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses

    The Journal of Neuroscience 32:8040–8052.

    https://doi.org/10.1523/JNEUROSCI.4240-11.2012

    • PubMed
    • Google Scholar
20. 1. de Jong APH
    2. Meijer M
    3. Saarloos I
    4. Cornelisse LN
    5. Toonen RFG
    6. Sørensen JB
    7. Verhage M

    (2016) Phosphorylation of synaptotagmin-1 controls a post-priming step in PKC-dependent presynaptic plasticity

    PNAS 113:5095–5100.

    https://doi.org/10.1073/pnas.1522927113

    • PubMed
    • Google Scholar
21. 1. Dulubova I
    2. Sugita S
    3. Hill S
    4. Hosaka M
    5. Fernandez I
    6. Südhof TC
    7. Rizo J

    (1999) A conformational switch in syntaxin during exocytosis: role of Munc18

    The EMBO Journal 18:4372–4382.

    https://doi.org/10.1093/emboj/18.16.4372

    • PubMed
    • Google Scholar
22. 1. Friedrich R
    2. Gottfried I
    3. Ashery U

    (2013) Munc13-1 translocates to the plasma membrane in a doc2b- and calcium-dependent manner

    Frontiers in Endocrinology 4:119.

    https://doi.org/10.3389/fendo.2013.00119

    • PubMed
    • Google Scholar
23. 1. Fulop T
    2. Smith C

    (2006) Physiological stimulation regulates the exocytic mode through calcium activation of protein kinase C in mouse chromaffin cells

    The Biochemical Journal 399:111–119.

    https://doi.org/10.1042/BJ20060654

    • PubMed
    • Google Scholar
24. 1. Genc O
    2. Kochubey O
    3. Toonen RF
    4. Verhage M
    5. Schneggenburger R

    (2014) Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release

    eLife 3:e01715.

    https://doi.org/10.7554/eLife.01715

    • PubMed
    • Google Scholar
25. 1. Grishanin RN
    2. Kowalchyk JA
    3. Klenchin VA
    4. Ann K
    5. Earles CA
    6. Chapman ER
    7. Gerona RRL
    8. Martin TFJ

    (2004) Caps acts at a prefusion step in dense-core vesicle exocytosis as a PIP2 binding protein

    Neuron 43:551–562.

    https://doi.org/10.1016/j.neuron.2004.07.028

    • PubMed
    • Google Scholar
26. 1. Grushin K
    2. Kalyana Sundaram RV
    3. Sindelar CV
    4. Rothman JE

    (2022) Munc13 structural transitions and oligomers that may choreograph successive stages in vesicle priming for neurotransmitter release

    PNAS 119:e2121259119.

    https://doi.org/10.1073/pnas.2121259119

    • PubMed
    • Google Scholar
27. 1. Holderith N
    2. Aldahabi M
    3. Nusser Z

    (2021) Selective enrichment of munc13-2 in presynaptic active zones of hippocampal pyramidal cells that innervate mglur1α expressing interneurons

    Frontiers in Synaptic Neuroscience 13:773209.

    https://doi.org/10.3389/fnsyn.2021.773209

    • PubMed
    • Google Scholar
28. 1. Houy S
    2. Groffen AJ
    3. Ziomkiewicz I
    4. Verhage M
    5. Pinheiro PS
    6. Sørensen JB

    (2017) Doc2B acts as a calcium sensor for vesicle priming requiring synaptotagmin-1, munc13-2 and snares

    eLife 6:e27000.

    https://doi.org/10.7554/eLife.27000

    • PubMed
    • Google Scholar
29. 1. Houy S
    2. Martins JS
    3. Mohrmann R
    4. Sørensen JB

    (2021) Measurements of exocytosis by capacitance recordings and calcium uncaging in mouse adrenal chromaffin cells

    Methods in Molecular Biology 2233:233–251.

    https://doi.org/10.1007/978-1-0716-1044-2_16

    • PubMed
    • Google Scholar
30. 1. James DJ
    2. Khodthong C
    3. Kowalchyk JA
    4. Martin TFJ

    (2008) Phosphatidylinositol 4,5-bisphosphate regulates SNARE-dependent membrane fusion

    The Journal of Cell Biology 182:355–366.

    https://doi.org/10.1083/jcb.200801056

    • PubMed
    • Google Scholar
31. 1. James DJ
    2. Khodthong C
    3. Kowalchyk JA
    4. Martin TFJ

    (2010) Phosphatidylinositol 4,5-bisphosphate regulation of SNARE function in membrane fusion mediated by CAPS

    Advances in Enzyme Regulation 50:62–70.

    https://doi.org/10.1016/j.advenzreg.2009.10.012

    • PubMed
    • Google Scholar
32. 1. Jockusch WJ
    2. Speidel D
    3. Sigler A
    4. Sørensen JB
    5. Varoqueaux F
    6. Rhee J-S
    7. Brose N

    (2007) CAPS-1 and CAPS-2 are essential synaptic vesicle priming proteins

    Cell 131:796–808.

    https://doi.org/10.1016/j.cell.2007.11.002

    • PubMed
    • Google Scholar
33. 1. Junge HJ
    2. Rhee J-S
    3. Jahn O
    4. Varoqueaux F
    5. Spiess J
    6. Waxham MN
    7. Rosenmund C
    8. Brose N

    (2004) Calmodulin and munc13 form a ca2+ sensor/effector complex that controls short-term synaptic plasticity

    Cell 118:389–401.

    https://doi.org/10.1016/j.cell.2004.06.029

    • PubMed
    • Google Scholar
34. 1. Kabachinski G
    2. Yamaga M
    3. Kielar-Grevstad DM
    4. Bruinsma S
    5. Martin TFJ

    (2014) CAPS and munc13 utilize distinct PIP2-linked mechanisms to promote vesicle exocytosis

    Molecular Biology of the Cell 25:508–521.

    https://doi.org/10.1091/mbc.E12-11-0829

    • PubMed
    • Google Scholar
35. 1. Kabachinski G
    2. Kielar-Grevstad DM
    3. Zhang X
    4. James DJ
    5. Martin TFJ

    (2016) Resident CAPS on dense-core vesicles docks and primes vesicles for fusion

    Molecular Biology of the Cell 27:654–668.

    https://doi.org/10.1091/mbc.E15-07-0509

    • PubMed
    • Google Scholar
36. 1. Kalyana Sundaram RV
    2. Jin H
    3. Li F
    4. Shu T
    5. Coleman J
    6. Yang J
    7. Pincet F
    8. Zhang Y
    9. Rothman JE
    10. Krishnakumar SS

    (2021) Munc13 binds and recruits SNAP25 to chaperone SNARE complex assembly

    FEBS Letters 595:297–309.

    https://doi.org/10.1002/1873-3468.14006

    • PubMed
    • Google Scholar
37. 1. Kang L
    2. He Z
    3. Xu P
    4. Fan J
    5. Betz A
    6. Brose N
    7. Xu T

    (2006) Munc13-1 is required for the sustained release of insulin from pancreatic beta cells

    Cell Metabolism 3:463–468.

    https://doi.org/10.1016/j.cmet.2006.04.012

    • PubMed
    • Google Scholar
38. 1. Kawabe H
    2. Mitkovski M
    3. Kaeser PS
    4. Hirrlinger J
    5. Opazo F
    6. Nestvogel D
    7. Kalla S
    8. Fejtova A
    9. Verrier SE
    10. Bungers SR
    11. Cooper BH
    12. Varoqueaux F
    13. Wang Y
    14. Nehring RB
    15. Gundelfinger ED
    16. Rosenmund C
    17. Rizzoli SO
    18. Südhof TC
    19. Rhee J-S
    20. Brose N

    (2017) ELKS1 localizes the synaptic vesicle priming protein bmunc13-2 to a specific subset of active zones

    The Journal of Cell Biology 216:1143–1161.

    https://doi.org/10.1083/jcb.201606086

    • PubMed
    • Google Scholar
39. 1. Kreutzberger AJB
    2. Kiessling V
    3. Liang B
    4. Seelheim P
    5. Jakhanwal S
    6. Jahn R
    7. Castle JD
    8. Tamm LK

    (2017) Reconstitution of calcium-mediated exocytosis of dense-core vesicles

    Science Advances 3:e1603208.

    https://doi.org/10.1126/sciadv.1603208

    • PubMed
    • Google Scholar
40. 1. Kreutzberger AJB
    2. Kiessling V
    3. Stroupe C
    4. Liang B
    5. Preobraschenski J
    6. Ganzella M
    7. Kreutzberger MAB
    8. Nakamoto R
    9. Jahn R
    10. Castle JD
    11. Tamm LK

    (2019) In vitro fusion of single synaptic and dense core vesicles reproduces key physiological properties

    Nature Communications 10:3904.

    https://doi.org/10.1038/s41467-019-11873-8

    • PubMed
    • Google Scholar
41. 1. Kuri BA
    2. Chan SA
    3. Smith CB

    (2009) PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity-dependent manner through a protein kinase C-dependent pathway

    Journal of Neurochemistry 110:1214–1225.

    https://doi.org/10.1111/j.1471-4159.2009.06206.x

    • PubMed
    • Google Scholar
42. 1. Kwan EP
    2. Xie L
    3. Sheu L
    4. Nolan CJ
    5. Prentki M
    6. Betz A
    7. Brose N
    8. Gaisano HY

    (2006) Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance

    Diabetes 55:1421–1429.

    https://doi.org/10.2337/db05-1263

    • PubMed
    • Google Scholar
43. 1. Li L
    2. Liu H
    3. Hall Q
    4. Wang W
    5. Yu Y
    6. Kaplan JM
    7. Hu Z

    (2019) A hyperactive form of unc-13 enhances ca²⁺ sensitivity and synaptic vesicle release probability in C. elegans

    Cell Reports 28:2979–2995.

    https://doi.org/10.1016/j.celrep.2019.08.018

    • PubMed
    • Google Scholar
44. 1. Lipstein N
    2. Schaks S
    3. Dimova K
    4. Kalkhof S
    5. Ihling C
    6. Kölbel K
    7. Ashery U
    8. Rhee J
    9. Brose N
    10. Sinz A
    11. Jahn O

    (2012) Nonconserved Ca (2+) /calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity

    Molecular and Cellular Biology 32:4628–4641.

    https://doi.org/10.1128/MCB.00933-12

    • PubMed
    • Google Scholar
45. 1. Lipstein N
    2. Sakaba T
    3. Cooper BH
    4. Lin K-H
    5. Strenzke N
    6. Ashery U
    7. Rhee J-S
    8. Taschenberger H
    9. Neher E
    10. Brose N

    (2013) Dynamic control of synaptic vesicle replenishment and short-term plasticity by ca(2+)-calmodulin-munc13-1 signaling

    Neuron 79:82–96.

    https://doi.org/10.1016/j.neuron.2013.05.011

    • PubMed
    • Google Scholar
46. 1. Lipstein N
    2. Chang S
    3. Lin K-H
    4. López-Murcia FJ
    5. Neher E
    6. Taschenberger H
    7. Brose N

    (2021) Munc13-1 is a ca²⁺-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission

    Neuron 109:3980–4000.

    https://doi.org/10.1016/j.neuron.2021.09.054

    • PubMed
    • Google Scholar
47. 1. Liu Y
    2. Schirra C
    3. Edelmann L
    4. Matti U
    5. Rhee J
    6. Hof D
    7. Bruns D
    8. Brose N
    9. Rieger H
    10. Stevens DR
    11. Rettig J

    (2010) Two distinct secretory vesicle-priming steps in adrenal chromaffin cells

    The Journal of Cell Biology 190:1067–1077.

    https://doi.org/10.1083/jcb.201001164

    • PubMed
    • Google Scholar
48. 1. Liu H
    2. Bai H
    3. Hui E
    4. Yang L
    5. Evans CS
    6. Wang Z
    7. Kwon SE
    8. Chapman ER

    (2014) Synaptotagmin 7 functions as a ca2+-sensor for synaptic vesicle replenishment

    eLife 3:e01524.

    https://doi.org/10.7554/eLife.01524

    • PubMed
    • Google Scholar
49. 1. Liu X
    2. Seven AB
    3. Camacho M
    4. Esser V
    5. Xu J
    6. Trimbuch T
    7. Quade B
    8. Su L
    9. Ma C
    10. Rosenmund C
    11. Rizo J

    (2016) Functional synergy between the Munc13 C-terminal C1 and C2 domains

    eLife 5:e13696.

    https://doi.org/10.7554/eLife.13696

    • PubMed
    • Google Scholar
50. 1. Lou X
    2. Scheuss V
    3. Schneggenburger R

    (2005) Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion

    Nature 435:497–501.

    https://doi.org/10.1038/nature03568

    • PubMed
    • Google Scholar
51. 1. Ma C
    2. Li W
    3. Xu Y
    4. Rizo J

    (2011) Munc13 mediates the transition from the closed syntaxin-munc18 complex to the SNARE complex

    Nature Structural & Molecular Biology 18:542–549.

    https://doi.org/10.1038/nsmb.2047

    • PubMed
    • Google Scholar
52. 1. Malenka RC
    2. Madison DV
    3. Nicoll RA

    (1986) Potentiation of synaptic transmission in the hippocampus by phorbol esters

    Nature 321:175–177.

    https://doi.org/10.1038/321175a0

    • PubMed
    • Google Scholar
53. 1. Man KNM
    2. Imig C
    3. Walter AM
    4. Pinheiro PS
    5. Stevens DR
    6. Rettig J
    7. Sørensen JB
    8. Cooper BH
    9. Brose N
    10. Wojcik SM

    (2015) Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis

    eLife 4:e10635.

    https://doi.org/10.7554/eLife.10635

    • PubMed
    • Google Scholar
54. 1. Maruyama IN
    2. Brenner S

    (1991) A phorbol ester/diacylglycerol-binding protein encoded by the unc-13 gene of Caenorhabditis elegans

    PNAS 88:5729–5733.

    https://doi.org/10.1073/pnas.88.13.5729

    • PubMed
    • Google Scholar
55. 1. Maximov A
    2. Lao Y
    3. Li H
    4. Chen X
    5. Rizo J
    6. Sørensen JB
    7. Südhof TC

    (2008) Genetic analysis of synaptotagmin-7 function in synaptic vesicle exocytosis

    PNAS 105:3986–3991.

    https://doi.org/10.1073/pnas.0712372105

    • PubMed
    • Google Scholar
56. 1. Michelassi F
    2. Liu H
    3. Hu Z
    4. Dittman JS

    (2017) A C1-C2 module in munc13 inhibits calcium-dependent neurotransmitter release

    Neuron 95:577–590.

    https://doi.org/10.1016/j.neuron.2017.07.015

    • PubMed
    • Google Scholar
57. 1. Milosevic I
    2. Sørensen JB
    3. Lang T
    4. Krauss M
    5. Nagy G
    6. Haucke V
    7. Jahn R
    8. Neher E

    (2005) Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells

    The Journal of Neuroscience 25:2557–2565.

    https://doi.org/10.1523/JNEUROSCI.3761-04.2005

    • PubMed
    • Google Scholar
58. 1. Mohrmann R
    2. Dhara M
    3. Bruns D

    (2015) Complexins: small but capable

    Cellular and Molecular Life Sciences 72:4221–4235.

    https://doi.org/10.1007/s00018-015-1998-8

    • PubMed
    • Google Scholar
59. 1. Nagy G
    2. Matti U
    3. Nehring RB
    4. Binz T
    5. Rettig J
    6. Neher E
    7. Sørensen JB

    (2002)

    Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment

    The Journal of Neuroscience 22:9278–9286.

    • PubMed
    • Google Scholar
60. 1. Nagy G
    2. Kim JH
    3. Pang ZP
    4. Matti U
    5. Rettig J
    6. Südhof TC
    7. Sørensen JB

    (2006) Different effects on fast exocytosis induced by synaptotagmin 1 and 2 isoforms and abundance but not by phosphorylation

    The Journal of Neuroscience 26:632–643.

    https://doi.org/10.1523/JNEUROSCI.2589-05.2006

    • PubMed
    • Google Scholar
61. 1. Neher E

    (2018) Neurosecretion: what can we learn from chromaffin cells

    Pflugers Archiv 470:7–11.

    https://doi.org/10.1007/s00424-017-2051-6

    • PubMed
    • Google Scholar
62. 1. Nguyen Truong CQ
    2. Nestvogel D
    3. Ratai O
    4. Schirra C
    5. Stevens DR
    6. Brose N
    7. Rhee J
    8. Rettig J

    (2014) Secretory vesicle priming by caps is independent of its SNARE-binding MUN domain

    Cell Reports 9:902–909.

    https://doi.org/10.1016/j.celrep.2014.09.050

    • PubMed
    • Google Scholar
63. 1. Nili U
    2. de Wit H
    3. Gulyas-Kovacs A
    4. Toonen RF
    5. Sørensen JB
    6. Verhage M
    7. Ashery U

    (2006) Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells

    Neuroscience 143:487–500.

    https://doi.org/10.1016/j.neuroscience.2006.08.014

    • PubMed
    • Google Scholar
64. 1. Orita S
    2. Naito A
    3. Sakaguchi G
    4. Maeda M
    5. Igarashi H
    6. Sasaki T
    7. Takai Y

    (1997) Physical and functional interactions of Doc2 and Munc13 in Ca2+-dependent exocytotic machinery

    The Journal of Biological Chemistry 272:16081–16084.

    https://doi.org/10.1074/jbc.272.26.16081

    • PubMed
    • Google Scholar
65. 1. Padmanarayana M
    2. Liu H
    3. Michelassi F
    4. Li L
    5. Betensky D
    6. Dominguez MJ
    7. Sutton RB
    8. Hu Z
    9. Dittman JS

    (2021) A unique C2 domain at the C terminus of munc13 promotes synaptic vesicle priming

    PNAS 118:11.

    https://doi.org/10.1073/pnas.2016276118

    • PubMed
    • Google Scholar
66. 1. Parisotto D
    2. Pfau M
    3. Scheutzow A
    4. Wild K
    5. Mayer MP
    6. Malsam J
    7. Sinning I
    8. Söllner TH

    (2014) An extended helical conformation in domain 3A of Munc18-1 provides a template for SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex assembly

    The Journal of Biological Chemistry 289:9639–9650.

    https://doi.org/10.1074/jbc.M113.514273

    • PubMed
    • Google Scholar
67. 1. Park YS
    2. Hur EM
    3. Choi BH
    4. Kwak E
    5. Jun DJ
    6. Park SJ
    7. Kim KT

    (2006) Involvement of protein kinase C-epsilon in activity-dependent potentiation of large dense-core vesicle exocytosis in chromaffin cells

    The Journal of Neuroscience 26:8999–9005.

    https://doi.org/10.1523/JNEUROSCI.2828-06.2006

    • PubMed
    • Google Scholar
68. 1. Pinheiro PS
    2. de Wit H
    3. Walter AM
    4. Groffen AJ
    5. Verhage M
    6. Sørensen JB

    (2013) Doc2B synchronizes secretion from chromaffin cells by stimulating fast and inhibiting sustained release

    The Journal of Neuroscience 33:16459–16470.

    https://doi.org/10.1523/JNEUROSCI.2656-13.2013

    • PubMed
    • Google Scholar
69. 1. Quade B
    2. Camacho M
    3. Zhao X
    4. Orlando M
    5. Trimbuch T
    6. Xu J
    7. Li W
    8. Nicastro D
    9. Rosenmund C
    10. Rizo J

    (2019) Membrane bridging by Munc13-1 is crucial for neurotransmitter release

    eLife 8:e42806.

    https://doi.org/10.7554/eLife.42806

    • PubMed
    • Google Scholar
70. 1. Rhee JS
    2. Betz A
    3. Pyott S
    4. Reim K
    5. Varoqueaux F
    6. Augustin I
    7. Hesse D
    8. Südhof TC
    9. Takahashi M
    10. Rosenmund C
    11. Brose N

    (2002) Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs

    Cell 108:121–133.

    https://doi.org/10.1016/s0092-8674(01)00635-3

    • PubMed
    • Google Scholar
71. 1. Richmond JE
    2. Weimer RM
    3. Jorgensen EM

    (2001) An open form of syntaxin bypasses the requirement for UNC-13 in vesicle priming

    Nature 412:338–341.

    https://doi.org/10.1038/35085583

    • PubMed
    • Google Scholar
72. 1. Rizo J

    (2018) Mechanism of neurotransmitter release coming into focus

    Protein Science 27:1364–1391.

    https://doi.org/10.1002/pro.3445

    • PubMed
    • Google Scholar
73. 1. Rosenmund C
    2. Sigler A
    3. Augustin I
    4. Reim K
    5. Brose N
    6. Rhee JS

    (2002) Differential control of vesicle priming and short-term plasticity by munc13 isoforms

    Neuron 33:411–424.

    https://doi.org/10.1016/s0896-6273(02)00568-8

    • PubMed
    • Google Scholar
74. 1. Rosmaninho-Salgado J
    2. Araújo IM
    3. Alvaro AR
    4. Duarte EP
    5. Cavadas C

    (2007) Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells

    Journal of Neurochemistry 103:896–903.

    https://doi.org/10.1111/j.1471-4159.2007.04899.x

    • PubMed
    • Google Scholar
75. 1. Schonn J-S
    2. Maximov A
    3. Lao Y
    4. Südhof TC
    5. Sørensen JB

    (2008) Synaptotagmin-1 and -7 are functionally overlapping ca2+ sensors for exocytosis in adrenal chromaffin cells

    PNAS 105:3998–4003.

    https://doi.org/10.1073/pnas.0712373105

    • PubMed
    • Google Scholar
76. 1. Shapira R
    2. Silberberg SD
    3. Ginsburg S
    4. Rahamimoff R

    (1987) Activation of protein kinase C augments evoked transmitter release

    Nature 325:58–60.

    https://doi.org/10.1038/325058a0

    • PubMed
    • Google Scholar
77. 1. Sharma S
    2. Lindau M

    (2018) Molecular mechanism of fusion pore formation driven by the neuronal SNARE complex

    PNAS 115:12751–12756.

    https://doi.org/10.1073/pnas.1816495115

    • PubMed
    • Google Scholar
78. 1. Sheu L
    2. Pasyk EA
    3. Ji J
    4. Huang X
    5. Gao X
    6. Varoqueaux F
    7. Brose N
    8. Gaisano HY

    (2003) Regulation of insulin exocytosis by Munc13-1

    The Journal of Biological Chemistry 278:27556–27563.

    https://doi.org/10.1074/jbc.M303203200

    • PubMed
    • Google Scholar
79. 1. Shu T
    2. Jin H
    3. Rothman JE
    4. Zhang Y

    (2020) Munc13-1 MUN domain and munc18-1 cooperatively chaperone SNARE assembly through a tetrameric complex

    PNAS 117:1036–1041.

    https://doi.org/10.1073/pnas.1914361117

    • PubMed
    • Google Scholar
80. 1. Sitarska E
    2. Xu J
    3. Park S
    4. Liu X
    5. Quade B
    6. Stepien K
    7. Sugita K
    8. Brautigam CA
    9. Sugita S
    10. Rizo J

    (2017) Autoinhibition of Munc18-1 modulates synaptobrevin binding and helps to enable Munc13-dependent regulation of membrane fusion

    eLife 6:e24278.

    https://doi.org/10.7554/eLife.24278

    • PubMed
    • Google Scholar
81. 1. Smith C
    2. Moser T
    3. Xu T
    4. Neher E

    (1998) Cytosolic Ca2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells

    Neuron 20:1243–1253.

    https://doi.org/10.1016/s0896-6273(00)80504-8

    • PubMed
    • Google Scholar
82. 1. Soma S
    2. Kuwashima H
    3. Matsumura C
    4. Kimura T

    (2009) Involvement of protein kinase C in the regulation of Na+/Ca2+ exchanger in bovine adrenal chromaffin cells

    Clinical and Experimental Pharmacology & Physiology 36:717–723.

    https://doi.org/10.1111/j.1440-1681.2009.05140.x

    • PubMed
    • Google Scholar
83. 1. Sørensen JB
    2. Nagy G
    3. Varoqueaux F
    4. Nehring RB
    5. Brose N
    6. Wilson MC
    7. Neher E

    (2003) Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23

    Cell 114:75–86.

    https://doi.org/10.1016/s0092-8674(03)00477-x

    • PubMed
    • Google Scholar
84. 1. Sørensen JB
    2. Wiederhold K
    3. Müller EM
    4. Milosevic I
    5. Nagy G
    6. de Groot BL
    7. Grubmüller H
    8. Fasshauer D

    (2006) Sequential N- to C-terminal SNARE complex assembly drives priming and fusion of secretory vesicles

    The EMBO Journal 25:955–966.

    https://doi.org/10.1038/sj.emboj.7601003

    • PubMed
    • Google Scholar
85. 1. Staal RGW
    2. Hananiya A
    3. Sulzer D

    (2008) Pkc theta activity maintains normal quantal size in chromaffin cells

    Journal of Neurochemistry 105:1635–1641.

    https://doi.org/10.1111/j.1471-4159.2008.05264.x

    • PubMed
    • Google Scholar
86. 1. Stevens DR
    2. Wu Z-X
    3. Matti U
    4. Junge HJ
    5. Schirra C
    6. Becherer U
    7. Wojcik SM
    8. Brose N
    9. Rettig J

    (2005) Identification of the minimal protein domain required for priming activity of Munc13-1

    Current Biology 15:2243–2248.

    https://doi.org/10.1016/j.cub.2005.10.055

    • PubMed
    • Google Scholar
87. 1. Südhof TC

    (2013) Neurotransmitter release: the last millisecond in the life of a synaptic vesicle

    Neuron 80:675–690.

    https://doi.org/10.1016/j.neuron.2013.10.022

    • PubMed
    • Google Scholar
88. 1. Tawfik B
    2. Martins JS
    3. Houy S
    4. Imig C
    5. Pinheiro PS
    6. Wojcik SM
    7. Brose N
    8. Cooper BH
    9. Sørensen JB

    (2021) Synaptotagmin-7 places dense-core vesicles at the cell membrane to promote munc13-2- and Ca2+-dependent priming

    eLife 10:e64527.

    https://doi.org/10.7554/eLife.64527

    • PubMed
    • Google Scholar
89. 1. van de Bospoort R
    2. Farina M
    3. Schmitz SK
    4. de Jong A
    5. de Wit H
    6. Verhage M
    7. Toonen RF

    (2012) Munc13 controls the location and efficiency of dense-core vesicle release in neurons

    The Journal of Cell Biology 199:883–891.

    https://doi.org/10.1083/jcb.201208024

    • PubMed
    • Google Scholar
90. 1. Varoqueaux F
    2. Sigler A
    3. Rhee JS
    4. Brose N
    5. Enk C
    6. Reim K
    7. Rosenmund C

    (2002) Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of munc13-mediated vesicle priming

    PNAS 99:9037–9042.

    https://doi.org/10.1073/pnas.122623799

    • PubMed
    • Google Scholar
91. 1. Varoqueaux F
    2. Sons MS
    3. Plomp JJ
    4. Brose N

    (2005) Aberrant morphology and residual transmitter release at the munc13-deficient mouse neuromuscular synapse

    Molecular and Cellular Biology 25:5973–5984.

    https://doi.org/10.1128/MCB.25.14.5973-5984.2005

    • PubMed
    • Google Scholar
92. 1. Verhage M
    2. Sørensen JB

    (2020) SNAREopathies: diversity in mechanisms and symptoms

    Neuron 107:22–37.

    https://doi.org/10.1016/j.neuron.2020.05.036

    • PubMed
    • Google Scholar
93. 1. Wang J
    2. Qiao JD
    3. Liu XR
    4. Liu DT
    5. Chen YH
    6. Wu Y
    7. Sun Y
    8. Yu J
    9. Ren RN
    10. Mei Z
    11. Liu YX
    12. Shi YW
    13. Jiang M
    14. Lin SM
    15. He N
    16. Li B
    17. Bian WJ
    18. Li BM
    19. Yi YH
    20. Su T
    21. Liu HK
    22. Gu WY
    23. Liao WP

    (2021a) UNC13B variants associated with partial epilepsy with favourable outcome

    Brain 144:3050–3060.

    https://doi.org/10.1093/brain/awab164

    • PubMed
    • Google Scholar
94. 1. Wang CC
    2. Weyrer C
    3. Fioravante D
    4. Kaeser PS
    5. Regehr WG

    (2021b) Presynaptic short-term plasticity persists in the absence of PKC phosphorylation of munc18-1

    The Journal of Neuroscience 41:7329–7339.

    https://doi.org/10.1523/JNEUROSCI.0347-21.2021

    • PubMed
    • Google Scholar
95. 1. Wierda KDB
    2. Toonen RFG
    3. de Wit H
    4. Brussaard AB
    5. Verhage M

    (2007) Interdependence of PKC-dependent and PKC-independent pathways for presynaptic plasticity

    Neuron 54:275–290.

    https://doi.org/10.1016/j.neuron.2007.04.001

    • PubMed
    • Google Scholar
96. 1. Xu J
    2. Camacho M
    3. Xu Y
    4. Esser V
    5. Liu X
    6. Trimbuch T
    7. Rizo J

    (2017) Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of munc13-1 C1C2BMUN

    eLife 6:22567.

    https://doi.org/10.7554/eLife.22567

    • Google Scholar
97. 1. Yang X
    2. Wang S
    3. Sheng Y
    4. Zhang M
    5. Zou W
    6. Wu L
    7. Kang L
    8. Rizo J
    9. Zhang R
    10. Xu T
    11. Ma C

    (2015) Syntaxin opening by the MUN domain underlies the function of Munc13 in synaptic-vesicle priming

    Nature Structural & Molecular Biology 22:547–554.

    https://doi.org/10.1038/nsmb.3038

    • PubMed
    • Google Scholar
98. 1. Zikich D
    2. Mezer A
    3. Varoqueaux F
    4. Sheinin A
    5. Junge HJ
    6. Nachliel E
    7. Melamed R
    8. Brose N
    9. Gutman M
    10. Ashery U

    (2008) Vesicle priming and recruitment by ubMunc13-2 are differentially regulated by calcium and calmodulin

    The Journal of Neuroscience 28:1949–1960.

    https://doi.org/10.1523/JNEUROSCI.5096-07.2008

    • PubMed
    • Google Scholar

Author details

1. Sébastien Houy

   Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark

   Contribution

   Conceptualization, Formal analysis, Investigation, Writing – review and editing

   Contributed equally with

   Joana S Martins

   Competing interests

   No competing interests declared

2. Joana S Martins

   Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark

   Contribution

   Conceptualization, Formal analysis, Investigation, Writing – review and editing

   Contributed equally with

   Sébastien Houy

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-6721-2935

3. Noa Lipstein

   1. Department of Molecular Neurobiology, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany
   2. Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany

   Contribution

   Investigation, Writing – review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-0755-5899

4. Jakob Balslev Sørensen

   Department of Neuroscience, University of Copenhagen, Copenhagen, Denmark

   Contribution

   Conceptualization, Supervision, Funding acquisition, Writing - original draft, Project administration

   For correspondence

   jakobbs@sund.ku.dk

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-5465-3769

• 893

  views

• 193

  downloads

• 3

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.